The effect of zoledronic acid on the fracture risk in men with osteoporosis
Prospective, placebo-controlled, double-blind, randomized studies on osteoporosis treatment with bisphosphonates in men are rare. This review focuses on a recent trial and compares the results with other studies.
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 January 2014
|
| In: |
Journal of endocrinological investigation
Year: 2014, Volume: 37, Issue: 3, Pages: 229-232 |
| ISSN: | 1720-8386 |
| DOI: | 10.1007/s40618-013-0038-5 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s40618-013-0038-5
|
| Author Notes: | R. Spiegel, P.P. Nawroth, C. Kasperk |
| Summary: | Prospective, placebo-controlled, double-blind, randomized studies on osteoporosis treatment with bisphosphonates in men are rare. This review focuses on a recent trial and compares the results with other studies. |
|---|---|
| Item Description: | Gesehen am 13.08.2020 |
| Physical Description: | Online Resource |
| ISSN: | 1720-8386 |
| DOI: | 10.1007/s40618-013-0038-5 |